Symmetry Partners’s Bio-Techne TECH Stock Holding History

Symmetry Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,160	Closed	-$262K	–	563
2022 Q4	$262K	Hold	3,160	–	–	0.02%	488
2022 Q3	$224K	Hold	3,160	–	–	0.02%	508
2022 Q2	$274K	Hold	3,160	–	–	0.02%	481
2022 Q1	$342K	Hold	3,160	–	–	0.02%	475
2021 Q4	$409K	Sell	3,160 -372	-11%	-$45.6K	0.03%	454
2021 Q3	$427K	Buy	3,532 +492	+16%	+$59.9K	0.03%	469
2021 Q2	$342K	Hold	3,040	–	–	0.02%	540
2021 Q1	$290K	Sell	3,040 -12	-0.4%	-$1.09K	0.02%	564
2020 Q4	$242K	Sell	3,052 -616	-17%	-$44.6K	0.02%	559
2020 Q3	$227K	Buy	+3,668	New	+$239K	0.02%	546
2019 Q2	–	Sell	-1,580	Closed	-$78K	–	416
2019 Q1	$78K	Hold	1,580	–	–	0.01%	394
2018 Q4	$57K	Buy	+1,580	New	+$66K	0.01%	356

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Symmetry Partners's TECH Position: Q1 2023 in Review

Symmetry Partners sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 3,160 shares — an estimated $262K sold.

Symmetry Partners first reported a position in TECH in Q4 2018 and held it in 12 quarters. The position peaked at $427K in Q3 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Symmetry Partners reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
Symmetry Partners sold 3,160 Bio-Techne shares in Q1 2023, an estimated $262K.
Symmetry Partners first reported a position in Bio-Techne in Q4 2018 and held it in 12 quarters.
Symmetry Partners's Bio-Techne position peaked at $427K in Q3 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Symmetry Partners's 13F filing for Q1 2023, filed 3 Apr 2023.